ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "1. 💔🩸⚖️ Aspirin, Anticoagulants & Harm: Rethinking Dual Therapy in Stable CAD"
Episode Synopsis
💊🫀 Aspirin in the Crosshairs? The AQUATIC Trial (NEJM, Aug 2025) raises sharp questions on dual-pathway therapy in chronic coronary syndrome (CCS) patients already on long-term anticoagulation. 📉 Adding aspirin led to: • ↑ Ischemic events (HR 1.53; P=0.02) • ↑ Mortality (HR 1.72; P=0.01) • ↑ Major bleeding (HR 3.35; P
In God we trust